Skip to main content
Year archive

Opthea Ltd — 2019 filings

All 59 regulatory filings released by Opthea Ltd (OPT) in 2019, sourced directly from the official regulator.

59 Filings
2019 Period
2019 filings (59)
Filing Released Lang
Ceasing to be a substantial holder 6 pages 296.4KB
Regulatory Filings
2019-12-15 English
Becoming a substantial holder 31 pages 713.7KB
Regulatory Filings
2019-12-11 English
Ceasing to be a substantial holder 12 pages 186.4KB
Regulatory Filings
2019-12-09 English
Change in substantial holding 3 pages 1.5MB
Regulatory Filings
2019-12-09 English
Completion of A$50 million Institutional Placement 3 pages 180.6KB
Regulatory Filings
2019-12-05 English
Becoming a substantial holder 31 pages 195.7KB
Regulatory Filings
2019-12-04 English
Opthea Raises A$50 million in Institutional Placement 3 pages 80.4KB
Regulatory Filings
2019-12-01 English
Opthea Equity Raising Presentation 57 pages 9.9MB
Regulatory Filings
2019-12-01 English
Appendix 3B 8 pages 166.5KB
Regulatory Filings
2019-12-01 English
Ceasing to be a substantial holder 7 pages 317.2KB
Regulatory Filings
2019-11-27 English
Becoming a substantial holder 24 pages 605.8KB
Regulatory Filings
2019-11-25 English
Ceasing to be a substantial holder 10 pages 158.4KB
Regulatory Filings
2019-11-24 English
Opthea Chairman Address to the 2019 AGM 3 pages 69.8KB
Regulatory Filings
2019-11-20 English
Opthea CEO Presentation to the 2019 AGM 36 pages 1.7MB
Regulatory Filings
2019-11-20 English
Results of Meeting 2 pages 147.8KB
Regulatory Filings
2019-11-20 English
Change in substantial holding 18 pages 109.7KB
Regulatory Filings
2019-11-19 English
Opthea Clinical Data Published in Leading Ophthalmic Journal 3 pages 98.4KB
Regulatory Filings
2019-10-28 English
Ceasing to be a substantial holder 9 pages 334.4KB
Regulatory Filings
2019-10-28 English
Becoming a substantial holder 24 pages 560.1KB
Regulatory Filings
2019-10-23 English
Annual Report 2019 68 pages 3.6MB
Regulatory Filings
2019-10-17 English
Appendix 4G and Corporate Governance Statement 2019 22 pages 953.5KB
Regulatory Filings
2019-10-17 English
Notice of Annual General Meeting and Proxy Form 10 pages 917.3KB
Regulatory Filings
2019-10-17 English
Opthea Presents Additional Data from Ph2b Trial at OIS in US 4 pages 126.7KB
Regulatory Filings
2019-10-10 English
Opthea Presentation for Ophthalmology Innovation Summit 37 pages 1.0MB
Regulatory Filings
2019-10-10 English
Change in substantial holding 13 pages 323.0KB
Regulatory Filings
2019-10-08 English
Ceasing to be a substantial holder 2 pages 106.0KB
Regulatory Filings
2019-10-07 English
Becoming a substantial holder 20 pages 344.8KB
Regulatory Filings
2019-10-07 English
Opthea to Present at Ophthalmology Innovation Summit in US 2 pages 110.6KB
Regulatory Filings
2019-10-02 English
Opthea Receives A$14.6m R&D Tax Incentive 2 pages 60.4KB
Regulatory Filings
2019-09-30 English
Appendix 3B 9 pages 156.4KB
Regulatory Filings
2019-09-29 English
Change in substantial holding 2 pages 123.4KB
Regulatory Filings
2019-09-12 English
Opthea Presents Positive Phase 2b Data at EURETINA Congress 3 pages 79.2KB
Regulatory Filings
2019-09-05 English
Opthea Presentation for EURETINA Congress 17 pages 1.0MB
Regulatory Filings
2019-09-05 English
Opthea Ph2b of OPT-302 in wAMD to be Presented at EURETINA 3 pages 73.6KB
Regulatory Filings
2019-09-03 English
Change in substantial holding 3 pages 97.0KB
Regulatory Filings
2019-08-28 English
Change in substantial holding 2 pages 61.4KB
Regulatory Filings
2019-08-26 English
Change in substantial holding 3 pages 58.5KB
Regulatory Filings
2019-08-18 English
Change in substantial holding 2 pages 84.0KB
Regulatory Filings
2019-08-14 English
Appendix 3B 9 pages 155.8KB
Regulatory Filings
2019-08-13 English
Change in substantial holding 8 pages 335.8KB
Regulatory Filings
2019-08-13 English
Becoming a substantial holder 4 pages 173.0KB
Regulatory Filings
2019-08-13 English
Preliminary Final Report 56 pages 601.4KB
Regulatory Filings
2019-08-08 English
Opthea Meets Primary Endpoint in Phase 2b Study of OPT-302 5 pages 266.8KB
Regulatory Filings
2019-08-06 English
Trading Halt 2 pages 295.5KB
Regulatory Filings
2019-08-04 English
Opthea to Host Investor Teleconference 3 pages 67.0KB
Regulatory Filings
2019-08-04 English
Opthea European Patent Application to be Granted 3 pages 73.1KB
Regulatory Filings
2019-07-29 English
Opthea Provides Timing Update on OPT-302 Clinical Trials 3 pages 69.6KB
Regulatory Filings
2019-07-21 English
Change in substantial holding 2 pages 342.4KB
Regulatory Filings
2019-06-03 English
Opthea Completes Final Patient Visit in Phase 2b wAMD Trial 3 pages 116.9KB
Regulatory Filings
2019-05-14 English
Appendix 3B 12 pages 179.7KB
Regulatory Filings
2019-04-11 English
Change of Director's Interest Notice - MB 4 pages 165.2KB
Regulatory Filings
2019-04-04 English
Appendix 3B 12 pages 178.2KB
Regulatory Filings
2019-03-18 English
Change of Director's Interest Notice - MB 3 pages 151.5KB
Regulatory Filings
2019-03-18 English
Change of Director's Interest Notice - GK 3 pages 159.3KB
Regulatory Filings
2019-03-18 English
Change of Director's Interest Notice - MS 3 pages 158.2KB
Regulatory Filings
2019-03-18 English
Opthea Added to the S&P/ASX All Ordinaries Index 2 pages 91.2KB
Regulatory Filings
2019-03-17 English
Opthea Ph2b Trial Advances With 2nd Positive Safety Review 3 pages 151.0KB
Regulatory Filings
2019-03-06 English
Opthea Half Year Report and Accounts 25 pages 880.4KB
Regulatory Filings
2019-02-24 English
Opthea Granted Japanese Patent Covering OPT-302 3 pages 85.0KB
Regulatory Filings
2019-01-28 English